Sponsor content
270 result(s) found, displaying 71 to 80
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution.
-
Prescription medicine registrationActive ingredients: amivantamab.
-
Australian Public Assessment Report (AusPAR)For the treatment of adult patients with relapsing forms of multiple sclerosis
-
Australian Public Assessment Report (AusPAR)AusPAR for DARZALEX SC (daratumumab) for the treatment of light chain AL amyloidosis
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 140 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 280 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 560 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IMBRUVICA ibrutinib 420 mg film-coated tablet blister.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 100 mg solution for injection pre-filled pen (One-Press (R) patient controlled injector).